Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in Escherichia coli Isolated in Clinical Urine Samples.

dc.contributor.authorSorlozano-Puerto, Antonio
dc.contributor.authorLopez-Machado, Isaac
dc.contributor.authorAlbertuz-Crespo, Maria
dc.contributor.authorMartinez-Gonzalez, Luis Javier
dc.contributor.authorGutierrez-Fernandez, Jose
dc.date.accessioned2025-01-07T16:51:19Z
dc.date.available2025-01-07T16:51:19Z
dc.date.issued2020-08-24
dc.description.abstractFosfomycin and nitrofurantoin are antibiotics of choice to orally treat non-complicated urinary tract infections (UTIs) of community origin because they remain active against bacteria resistant to other antibiotics. However, epidemiologic surveillance studies have detected a reduced susceptibility to these drugs. The objective of this study was to determine possible mechanisms of resistance to these antibiotics in clinical isolates of fosfomycin- and/or nitrofurantoin-resistant UTI-producing Escherichia coli. We amplified and sequenced murA, glpT, uhpT, uhpA, ptsI, cyaA, nfsA, nfsB, and ribE genes, and screened plasmid-borne fosfomycin-resistance genes fosA3, fosA4, fosA5, fosA6, and fosC2 and nitrofurantoin-resistance genes oqxA and oqxB by polymerase chain reaction. Among 29 isolates studied, 22 were resistant to fosfomycin due to deletion of uhpT and/or uhpA genes, and 2 also possessed the fosA3 gene. Some modifications detected in sequences of NfsA (His11Tyr, Ser33Arg, Gln67Leu, Cys80Arg, Gly126Arg, Gly154Glu, Arg203Cys), NfsB (Gln44His, Phe84Ser, Arg107Cys, Gly192Ser, Arg207His), and RibE (Pro55His), and the production of truncated NfsA (Gln67 and Gln147) and NfsB (Glu54), were associated with nitrofurantoin resistance in 15/29 isolates; however, the presence of oqxAB plasmid genes was not detected in any isolate. Resistance to fosfomycin was associated with the absence of transporter UhpT expression and/or the presence of antibiotic-modifying enzymes encoded by fosA3 plasmid-mediated gene. Resistance to nitrofurantoin was associated with modifications of NfsA, NfsB, and RibE proteins. The emergence and spread of these resistance mechanisms, including transferable resistance, could compromise the future usefulness of fosfomycin and nitrofurantoin against UTIs. Furthermore, knowledge of the genetic mechanisms underlying resistance may lead to rapid DNA-based testing for resistance.
dc.identifier.doi10.3390/antibiotics9090534
dc.identifier.issn2079-6382
dc.identifier.pmcPMC7558542
dc.identifier.pmid32847131
dc.identifier.pubmedURLhttps://pmc.ncbi.nlm.nih.gov/articles/PMC7558542/pdf
dc.identifier.unpaywallURLhttps://www.mdpi.com/2079-6382/9/9/534/pdf?version=1598333731
dc.identifier.urihttps://hdl.handle.net/10668/28031
dc.issue.number9
dc.journal.titleAntibiotics (Basel, Switzerland)
dc.journal.titleabbreviationAntibiotics (Basel)
dc.language.isoen
dc.organizationInstituto de Investigación Biosanitaria de Granada (ibs.GRANADA)
dc.pubmedtypeJournal Article
dc.rightsAttribution 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subjectEscherichia coli
dc.subjectantimicrobial resistance
dc.subjectfosfomycin
dc.subjectnitrofurantoin
dc.titleCharacterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in Escherichia coli Isolated in Clinical Urine Samples.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number9

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PMC7558542.pdf
Size:
945.88 KB
Format:
Adobe Portable Document Format